BioSante Pharmaceuticals, Inc. (BPAX)

[lurazh]

10-K is out
http://biz.yahoo.com/e/130228/bpax10-k.html

BioSante believes that the merger of the two companies will be able to create more value than BioSante could achieve individually. The combined company that will result from the merger will be a fully integrated specialty branded and generic pharmaceutical company focused on developing, manufacturing and marketing branded and generic prescription pharmaceuticals. Although the exact timing of completion of the merger cannot be predicted with certainty, each company has scheduled a special meeting of its stockholders for March 15, 2013 to consider and vote on certain matters in connection with the merger. If the merger is approved by BioSante's and ANI's stockholders and the other conditions to closing are satisfied, it is anticipated that the merger will be completed as soon as reasonably practicable after the special meetings of stockholders.

etc...